IRIS Institutional Research Information System - AIR Archivio Istituzionale della Ricerca

MAZZAFERRO, VINCENZO MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 27.292
NA - Nord America 12.864
AS - Asia 11.220
SA - Sud America 733
AF - Africa 231
OC - Oceania 199
Continente sconosciuto - Info sul continente non disponibili 26
Totale 52.565
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.177
DE - Germania 11.033
GB - Regno Unito 6.242
CN - Cina 5.479
IT - Italia 3.728
SE - Svezia 1.224
IN - India 1.058
FR - Francia 1.036
SG - Singapore 915
ES - Italia 871
IE - Irlanda 830
JP - Giappone 684
VN - Vietnam 627
TR - Turchia 587
HK - Hong Kong 547
CA - Canada 472
KR - Corea 364
FI - Finlandia 330
BR - Brasile 253
NL - Olanda 246
ID - Indonesia 232
AR - Argentina 197
DK - Danimarca 189
MX - Messico 182
UA - Ucraina 182
TW - Taiwan 180
AU - Australia 175
RU - Federazione Russa 170
BE - Belgio 154
GR - Grecia 149
CH - Svizzera 146
PT - Portogallo 131
CO - Colombia 120
TH - Thailandia 119
AT - Austria 115
PL - Polonia 106
RO - Romania 94
IR - Iran 76
EU - Europa 72
CL - Cile 69
EG - Egitto 67
PE - Perù 53
NO - Norvegia 52
PK - Pakistan 50
RS - Serbia 50
MY - Malesia 48
PH - Filippine 48
HU - Ungheria 46
IL - Israele 38
SI - Slovenia 35
ZA - Sudafrica 35
CZ - Repubblica Ceca 34
SA - Arabia Saudita 32
TN - Tunisia 30
NZ - Nuova Zelanda 23
HR - Croazia 21
EC - Ecuador 20
SK - Slovacchia (Repubblica Slovacca) 20
MA - Marocco 17
BD - Bangladesh 16
NP - Nepal 16
AE - Emirati Arabi Uniti 15
BY - Bielorussia 14
DZ - Algeria 13
LT - Lituania 13
NG - Nigeria 13
SC - Seychelles 13
GT - Guatemala 11
LB - Libano 11
GH - Ghana 10
KZ - Kazakistan 9
KE - Kenya 8
UZ - Uzbekistan 8
VE - Venezuela 8
EE - Estonia 7
IQ - Iraq 7
JO - Giordania 7
BG - Bulgaria 6
CY - Cipro 6
UY - Uruguay 6
YE - Yemen 6
BO - Bolivia 5
LY - Libia 5
MD - Moldavia 5
MO - Macao, regione amministrativa speciale della Cina 5
PR - Porto Rico 5
BJ - Benin 4
LK - Sri Lanka 4
NI - Nicaragua 4
BF - Burkina Faso 3
BN - Brunei Darussalam 3
CR - Costa Rica 3
DO - Repubblica Dominicana 3
KH - Cambogia 3
LV - Lettonia 3
MK - Macedonia 3
MM - Myanmar 3
MN - Mongolia 3
OM - Oman 3
UG - Uganda 3
Totale 52.573
Salva come PNG Salva come JPEG
Città #
Frankfurt am Main 9.565
Southend 5.481
Chandler 1.319
Milan 1.026
Princeton 852
Seattle 838
Dublin 803
Beijing 756
Fairfield 746
Wilmington 741
Hangzhou 644
Houston 519
Ashburn 516
Singapore 474
Shanghai 447
Ann Arbor 438
Nanjing 395
Redwood City 375
Woodbridge 346
Dearborn 299
Bengaluru 295
Des Moines 294
Cambridge 261
Guangzhou 259
Dong Ket 247
Rome 246
New York 191
Toronto 189
Boardman 174
Madrid 163
Berlin 162
Jinan 161
Central 156
Barcelona 147
Istanbul 142
Shenyang 142
Jakarta 141
Tokyo 137
Seoul 136
Paris 127
Hanover 125
Hong Kong 125
London 122
Ottawa 113
Helsinki 112
Los Angeles 110
Wuhan 110
Changsha 104
Phoenix 102
San Diego 102
Buenos Aires 101
Taipei 94
Chengdu 92
Chicago 89
Nanchang 89
Hebei 87
Hyderabad 86
Jacksonville 85
Redmond 85
Andover 81
Bologna 81
Tianjin 81
Mountain View 80
Munich 79
Zhengzhou 77
Bühl 76
Delhi 73
Brussels 72
Bogotá 69
São Paulo 65
Mumbai 62
Athens 60
Central District 60
Pittsburgh 58
Fuzhou 57
Hefei 57
Mexico City 57
Naples 56
Ankara 55
Bangkok 53
Padova 53
Fremont 52
Grafing 51
Duncan 47
Jiaxing 47
Lima 47
Turin 46
Chongqing 45
Florence 45
Santiago 45
Silver Spring 44
Valencia 44
Moscow 43
Amsterdam 41
Hanoi 41
San Francisco 41
San Jose 41
Vienna 40
Malatya 39
Zurich 39
Totale 34.583
Salva come PNG Salva come JPEG
Nome #
Liver Transplantation for Hepatocellular Carcinoma. Working Group Report from the ILTS Transplant Oncology Consensus Conference 2.487
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update 2.107
Liver resection and transplantation for intrahepatic cholangiocarcinoma 1.522
Development of a prognostic score to predict response to Yttrium-90 radioembolization for hepatocellular carcinoma with portal vein invasion 1.123
Death following pulmonary complications of surgery before and during the SARS-CoV-2 pandemic 1.000
First-in-Human Phase I Study of Fisogatinib (BLU-554) Validates Aberrant Fibroblast Growth Factor 19 Signaling as a Driver Event in Hepatocellular Carcinoma 956
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma 855
The EASL–Lancet Liver Commission: protecting the next generation of Europeans against liver disease complications and premature mortality 770
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice 705
Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study 651
Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification 520
Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial 459
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma 442
Importance of early nutritional screening in patients with gastric cancer 440
Management of asymptomatic sporadic non-functioning pancreatic neuroendocrine neoplasms no larger than 2 cm: interim analysis of prospective ASPEN trial 403
Sorafenib in advanced hepatocellular carcinoma 372
Machine learning risk prediction of mortality for patients undergoing surgery with perioperative SARS-CoV-2: The COVIDSurg mortality score 333
Defining Global Benchmarks for Laparoscopic Liver Resections: An International Multicenter Study 328
Delaying surgery for patients with a previous SARS-CoV-2 infection 326
Phase II Studies with Refametinib or Refametinib plus Sorafenib in Patients with RAS-mutated Hepatocellular Carcinoma 316
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma : subanalyses of a phase III trial 264
Heterologous and cross-species tropism of cancer-derived extracellular vesicles 264
Transplantation of autologous extracellular vesicles for cancer-specific targeting 264
Changes in surgicaL behaviOrs dUring the CoviD-19 pandemic : the SICE CLOUD19 Study 264
Endo-therapies for biliary duct-to-duct anastomotic stricture after liver transplantation: outcomes of a nationwide survey 251
Cancer-derived EVs show tropism for tissues at early stage of neoplastic transformation 245
Including mRECIST in the Metroticket 2.0 criteria improves prediction of hepatocellular carcinoma-related death after liver transplant 241
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection : an international cohort study 228
A prospective randomized, open-labeled; trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma 221
Resection of Retro-Hepatic Vena Cava (RHVC) En-bloc with Caudate Lobe without Vascular Exclusion for a Low Grade Leiomyosarcoma of Inferior Vena Cava 221
Preliminary Analysis of the Impact of COVID-19 Outbreak on Italian Liver Transplant Programs 217
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma : multicentre, open-label, phase II safety study 210
Thirty-day mortality and five-year survival in thoracic surgery: "real-world" assessment of outcomes from a single-institution audit 209
Permanent Pancreatic Duct Occlusion With Neoprene-based Glue Injection After Pancreatoduodenectomy at High Risk of Pancreatic Fistula : A Prospective Clinical Study 202
Controversy Over Liver Transplantation or Resection for Neuroendocrine Liver Metastasis: Tumor Biology Cuts the Deal 200
Endoscopic ultrasound-guided fine needle aspiration of splenic vein thrombosis: a novel approach to the portal venous system 196
A modified technique of orthotopic transplant of the kidney in rabbits 194
Development of a prognostic scoring system for resectable hepatocellular carcinoma 192
Excellent 5-year overall survival in patients with HBV-related cirrhosis undergoing liver transplantation for hepatocellular carcinoma 189
Evidence of distinct tumour-propagating cell populations with different properties in primary human hepatocellular carcinoma 186
Postrecurrence Survival After Liver Transplantation for Liver Metastases From Neuroendocrine Tumors 186
Strict selection alone of patients undergoing liver transplantation for hilar cholangiocarcinoma is associated with improved survival 185
Liver transplantation for adenomatosis: European experience 183
Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs) 179
Squaring the circle of selection and allocation in liver transplantation for HCC: An adaptive approach 178
Liver resection and transplantation for metastases from gastroenteropancreatic neuroendocrine tumors 175
Elective cancer surgery in COVID-19-free surgical pathways during the SARS-CoV-2 pandemic: An international, multicenter, comparative cohort study 174
Trans-arterial radioembolization for intermediate-advanced hepatocellular carcinoma: a budget impact analysis 173
Correction to: Diffusion, outcomes and implementation of minimally invasive liver surgery: a snapshot from the I Go MILS (Italian Group of Minimally Invasive Liver Surgery) Registry 172
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma : available evidence and expert opinion on the use of transarterial chemoembolization 171
Competing risk analysis on outcome after hepatic resection of hepatocellular carcinoma in cirrhotic patients 171
Endoscopic ultrasound-guided esophagoenterostomy for a completely obstructed surgical anastomosis 168
Comparison Between Swan-Ganz Catheter and Minimally Invasive Hemodynamic Monitoring During Liver Transplantation: Report of a Monocentric Case Series 167
Post-liver transplant intrahepatic cholestasis : etiology, clinical presentation, therapy 165
Combination therapy with adefovir dipivoxil (ADV)and lamivudine (LAM) in LAM-resistant patients enlisted for liver transplantation 163
Thrombosis after liver transplantation for hepatocellular carcinoma 163
Systemic Administration and Targeted Delivery of Immunogenic Oncolytic Adenovirus Encapsulated in Extracellular Vesicles for Cancer Therapies 162
ARQ 087, an oral pan- fibroblast growth factor receptor (FGFR) inhibitor, in patients (pts) with advanced and/or metastatic intrahepatic cholangiocarcinoma (iCCA) 161
Immunotherapies for hepatocellular carcinoma 159
Systemic Treatment of Patients With Gastrointestinal Cancers During the COVID-19 Outbreak : COVID-19-adapted Recommendations of the National Cancer Institute of Milan 157
Clinical impact of Pancreatic metastases from renal cell carcinoma : A multicenter retrospective analysis 155
Derazantinib (ARQ 087) in advanced or inoperable FGFR2 gene fusion-positive intrahepatic cholangiocarcinoma. 155
Clinical Behavior and Treatment Response of Epstein-Barr Virus–Positive Metastatic Gastric Cancer : Implications for the Development of Future Trials 155
Evolution of minimally invasive techniques and surgical outcomes of ALPPS in Italy: a comprehensive trend analysis over 10 years from a national prospective registry 152
A multicenter italian experience in spli-liver transplantation : 10 year follow-up of a case control study 152
Assessment of insulin sensitivity based on a fasting blood sample in men with liver cirrhosis before and after liver transplantation 152
Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry 151
Liver Match, a prospective observational cohort study on liver transplantation in Italy : study design and current practice of donor-recipient matching 150
Trans-arterial radioembolization in intermediate-advanced hepatocellular carcinoma: systematic review and meta-analyses 149
Assessing Competing Risks for Death Following Liver Transplantation for Hepatocellular Carcinoma 148
Amino acid kinetics during the anhepatic phase of liver transplantation 147
Clinical and molecular determinants of extrahepatic disease progression in patients with metastatic colorectal cancer with liver-limited metastases deemed initially unresectable 145
GENOTIPI DELL'HCV IN PAZIENTI SOTTOPOSTI A TRAPIANTO DI FEGATO PER EPATOCARCINOMA SU CIRROSI 144
Massive APOBEC3 editing of hepatitis B viral DNA in cirrhosis 144
Microenvironment and tumor inflammatory features improve prognostic prediction in gastro-entero-pancreatic neuroendocrine neoplasms 144
Succinate dehydrogenase B subunit immunohistochemical expression predicts aggressiveness in well differentiated neuroendocrine tumors of the ileum 144
Perioperative Bevacizumab-based Triplet Chemotherapy in Patients with Potentially Resectable Colorectal Cancer Liver Metastases 140
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants 139
Prophylaxis of hepatitis B virus recurrence after liver transplantation in carriers of lamivudine-resistant mutants 137
Perspectives from Italy during the COVID-19 pandemic: nationwide survey-based focus on minimally invasive HPB surgery 137
A prospective policy development to increase split-liver transplantation for 2 adult recipients: Results of a 12-year multicenter collaborative study 136
Activity and safety of RAD001 (everolimus) in patients affected by biliary tract cancer progressing after prior chemotherapy : a phase II ITMO study 136
Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets 135
Metformin Use Is Associated With Longer Progression-Free Survival of Patients With Diabetes and Pancreatic Neuroendocrine Tumors Receiving Everolimus and/or Somatostatin Analogues. 135
Transarterial chemoembolization using 40 µm drug eluting beads for hepatocellular carcinoma 135
Preliminary experience on safety of regorafenib after sorafenib failure in recurrent hepatocellular carcinoma after liver transplantation 134
EASL-EORTC clinical practice guidelines : management of hepatocellular carcinoma 134
Propensity-score Matched and Coarsened-exact Matched Analysis Comparing Robotic and Laparoscopic Major Hepatectomies: An International Multicenter Study of 4822 Cases 133
Hepatic stem cell characterization in tumoral and non-tumoral liver specimens from patients with hepatocellular carcinoma 132
Pathological response after neoadjuvant bevacizumab- or cetuximab-based chemotherapy in resected colorectal cancer liver metastases 132
HCC recurrence in HCV-infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs - a post-hoc analysis 129
COVID-19 in long-term liver transplant patients: preliminary experience from an Italian transplant centre in Lombardy 129
Behind D-MELD : The role of primary indication (HCV or HBV) as significant covariate in the outcome prediction after liver transplants 128
Ki-67 and presence of liver metastases identify different progression-risk classes in pancreatic neuroendocrine neoplasms (pNEN) undergoing resection 128
EXTRACELLULAR VESICLES TO DELIVER THERAPEUTIC OR DIAGNOSTIC DRUGS 128
Early outcomes and complications following cardiac surgery in patients testing positive for coronavirus disease 2019: An international cohort study 128
Identification of an Immune-specific Class of Hepatocellular Carcinoma, Based on Molecular Features 127
Basi scientifiche per la definizione di linee-guida in ambito clinico per i tumori neuroendocrini del tratto Gastro-Entero-Pancreatico (GEP) 126
Impact of diabetes and metformin use on enteropancreatic neuroendocrine tumors : Post hoc analysis of the CLARINET study 125
Mutations within the CD81-binding sites and hypervariable region 2 of the envelope 2 protein and hepatitis C recurrence after liver transplantation 124
Totale 29.539
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20205.085 583 148 149 426 407 562 467 380 717 642 307 297
2020/20215.775 335 371 423 306 510 596 360 434 661 437 530 812
2021/20226.656 439 367 244 474 473 446 516 522 753 696 480 1.246
2022/202310.483 799 603 524 1.169 1.195 1.719 939 1.082 799 379 708 567
2023/202416.718 474 591 649 668 1.206 880 2.354 2.047 1.109 2.018 2.367 2.355
2024/2025766 766 0 0 0 0 0 0 0 0 0 0 0
Totale 55.443